Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
DBV Technologies
company
About
DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $25.50M
- Industries
- Biopharma,Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2002
- Number Of Employee
- 51 - 100
- Operating Status
- Active
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$25.50M
DBV Technologies has raised a total of
$25.50M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2011 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2011 | Series C | $25.50M | 1 |
InnoBio Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
DBV Technologies is funded by 1 investors.
InnoBio Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
InnoBio Fund
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
